Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Bufatas IV 60mg Injection
Manufacturer/Marketed By : INTAS PHARMACEUTICALS LTD
$123.87 $53.27
Bufatas IV 60mg injection is an anti-cancer (antineoplastic/cytotoxic) chemotherapy drug. It is an alkyl sulfonate belonging to the class alkylating agent. It is indicated for treating blood cancers, such as...
BUSULFAN
Active Pharmaceutical Ingredient
Bufatas IV 60mg Injection
$123.87
$53.27
Bufatas IV 60mg injection is an anti-cancer (antineoplastic/cytotoxic) chemotherapy drug. It is an alkyl sulfonate belonging to the class alkylating agent. It is indicated for treating blood cancers, such as chronic myelogenous leukemia (A type of cancer that causes an increase in white blood cells). It is given as a treatment to prepare the bone marrow to receive healthy blood-forming cells (stem cells) from a donor to replace their stem cells that have been destroyed by treatment with radiation or high doses of chemotherapy). Chronic myelogenous leukemia is an uncommon type of cancer that affects bone marrow (soft, spongy tissue that produces blood cells for your body). It causes an increase in white blood cell count. Common side effects of Bufatas IV 60 mg injections are decreased white blood cells count, dizziness, shortness of breath, mouth inflammation, nausea, diarrhea, difficulty sleeping, skin rashes, and fever. Drink plenty of fluids while you are taking this medicine. Bufatas IV 60 mg injection can cause a severe decrease in bone marrow activity. If you are taking any other prescribed or non-prescribed medications that decrease the blood cell count, talk to your healthcare professional before taking the medications. It affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, cough, mouth sores, or unusual bleeding or bruising.
Active Pharmaceutical Ingredient
Uses
• Hematopoietic progenitor cell transplantation
• Chronic myelogenous leukemia
• Polycythaemia vera (a type of cancer that causes an increase in red blood cells)
• Thrombocythemia (increased number of platelets in the blood)
• Myelofibrosis (type of blood cancer where scar tissues are formed in bone marrow)
• Hemoglobinopathies (a genetic disorder that produces abnormal hemoglobin)
• Brain Malignancies
Benefits
Bufatas IV 60 mg injection works by interfering with the DNA replication process, which is necessary for the cells to divide. It stops tumor growth by inhibiting cell division. It causes cytotoxicity by reversibly binding to nucleophilic groups on different cell components. Alkylation of DNA is most likely the crucial cytotoxic reaction that kills tumor cells. It damages the DNA and RNA of the cancer cells by stopping their growth and multiplication. They are combined with other medications to treat various lymphatic and solid cancers.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them. Bufatas IV 60 mg injection causes the following side effects
Most Common Side Effects
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Common Side Effects
• Thalassemia
• Skin rashes
• Hair loss
• Patches of dark skin
• Blood in urine
• Decrease in the number of blood cells and platelets
• Nausea and vomiting
• Jaundice
• Infertility and sterility
• Pneumonia Syndrome
• Itching
How To Use
Your physician will decide the formulation, dose, and duration of this therapy. The dose of Bufatas IV 60 mg injection depends on your blood cancer. If you are prescribed the injection, your healthcare professional will administer the injection. Do not self-administer. The injection is administered as an intravenous infusion into the vein. Don't stop the medication until or unless your doctor advises. If you missed the dose, do not take double the doses. Inform your physician about your missed dose.
Safety Advice
• Breast Feeding: If you are breastfeeding or plan to breastfeed your baby, talk to your physician because the drug may secrete in breast milk.
• Alcohol: It is not known whether it is safe to consume alcohol with Bufatas IV 60mg Injection. Please consult your doctor.
• Liver: Discuss with your physician before taking this medicine if you have liver problems.
• Lungs: It is unknown whether Bufatas IV 60mg Injection can be given to patients with lung diseases. Please inform your doctor if you have any lung problems.
• Driving: It is not known whether it is safe to consume alcohol with Bufatas IV 60mg Injection. Please consult your doctor.
• Pregnancy: If you are pregnant or planning to get pregnant, ask your doctor or pharmacist for advice before taking this medicine. This medicine can cause infertility. It applies to men and women because Bufatas IV 60 mg injection may harm your sperm or eggs. It may have harmful effects on your baby.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.